Health care organization and use of technological devices in people with diabetes in Italy: Result from a survey of the working group on diabetes and technology
Pitocco D, Laurenzi A, Tomaselli L, et al.
NMCD. Published online, 14 July 2022
Leggi
Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: perspective based on the updated evidence
Khunti K, Aroda VR, Bhatt DL, et al.
Diabetes Obes Metab. 2022, Jul 8
Leggi
Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials
Leite AR, Angélico-Gonçalves A, Vasques-Nóvoa F, et al
Diabetes Obes Metab. 2022 Aug;24(8):1676-1680
Leggi
The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial data
Zou X, Huang Q, Luo Y
Diabetologia. 2022 Jul 8. Online ahead of print
Leggi
Obesity and weight management for prevention and treatment of type 2 diabetes
Jiang C, Cifu AS, Sam S
JAMA. Published online, 11 July 2022
Leggi
FAD AMD – DIABETE E SCOMPENSO CARDIACO
Vi invitiamo a seguire questo nuovo percorso formativo dedicato ad un approfondimento in materia di diabete e scompenso cardiaco. Scopo dell’iniziativa è quello di acquisire capacità di diagnosi dello scompenso ed approfondire l’utilizzo dei farmaci innovativi (SGLT2i) al fine di ridurre il rischio di ricovero nelle persone con diabete tipo…
Leggi
AMD DIGITAL NETWORK – SCIENTIFIC TALK 2022-23
Carissimi Soci, come preannunciato in fase di avvio mandato, l’impegno di AMD per lo sviluppo di nuove proposte formative digital è confermato! Stiamo premendo l’acceleratore sull’AMD Digital Network con l’avvio dell’iniziativa AMD scientific talk. Una serie di webinar, della durata di circa novanta minuti, per integrare e arricchire l’offerta formativa societaria…
Leggi
Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes
Deng X, Zhang C, Wang P, et al.
J Clin Endocrinol Metab. 2022;107(7):1888-1896.
Leggi
Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes
Innes CWD, Henshall DE, Wilson B, et al.
Diabet Med. 2022;e14902.
Leggi